Search JIM Advanced Search

Journal of Chinese Integrative Medicine ›› 2007, Vol. 5 ›› Issue (2): 141-146.doi: 10.3736/jcim20070208

• Original Clinical Research • Previous Articles     Next Articles

A double-blind, randomized controlled trial of Chaige Qingre Granule in treating acute upper respiratory tract infection of wind heat syndrome

Jing Chang, Ying Zhang, Bing Mao, Lei Wang, Ting-qian Li, Rui-ming Zhang   

  1. Department of Integrated Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan Province 610041, China
  • Online:2007-03-31 Published:2007-03-15

Objective: To evaluate the safety and efficacy of Chaige Qingre Granule, a traditional Chinese compound herbal medicine, in treating acute upper respiratory tract infection of wind heat syndrome. 

Methods: A multi-center, double-blinded, randomized controlled trial was conducted. In the phase Ⅱ, 60 patients with acute upper respiratory tract infection were randomly divided into the trial group (n=30) and the control group (n=30). In the phase Ⅲ, 112 patients were randomly divided into the trial group (n=84) and the control group (n=28). The trial group received 6 g Chaige Qingre Granule, and the control group received 6 g Fufang Shuanghua Granule (another traditional Chinese compound herbal medicine). The two groups were all treated for 3 days and four times daily. Clinical symptoms, syndromes, adverse effect, blood, urine and stool test, hepatorenal function and electrocardiogram were examined before and after the treatment. 

Results: After treatment, the overall obvious response rates of the trial group and the control group were 78.57%, 82.14% (by per-protocol analysis) and 75.86%, 79.31% (by intention-to-treat analysis) respectively, and the overall response rates of the two groups were 96.43%, 100% (by per-protocol analysis) and 93.10%, 96.55% (by intention-to-treat analysis) respectively in phaseⅡ. There were no significant differences between the two groups (P>0.05). In the phase Ⅲ, the overall obvious response rates of the trial group and the control group were 90.54%, 73.08% (by per-protocol analysis) and 88.16%, 70.37% (by intention-to-treat analysis) respectively, and the overall response rates of the two groups were 94.59%, 96.15% (by per-protocol analysis) and 92.11%, 92.59% (by intention-to-treat analysis) respectively. There were no statistical differences between the two groups (P>0.05) too. No adverse effects were found in the trial. 

Conclusion: Chaige Qingre Granule is effective and safe in treating acute upper respiratory tract infection of wind heat syndrome.

Key words: herbal preparations, randomized controlled trials, doubleblinded method, respiratory tract infections, wind heat, traditional Chinese medicine

CLC Number: 

  • R562.2+1

Figure 1

Diagram of the randomized trial"

Table 1

Comparison of the baseline between two groups in phase Ⅱ (ITT)"

Items Trial Control t /χ2 P
Cases 29 229 21 21
Sex(M/F) ####### 5月24日 3.107 0.141
Mean age (x±s, year) 30.42±8.67 32.67±11.00 -0.863 0.392
Course (x±s, year) 1.28±0.45 1.43±0.50 -1.243 0.219
Severity (mild/moderate/severe) 10/19/0 13/16/0 0.649 0.592
Fever (none/mild/moderate/severe) 26/14/9/0 6/15/8/0 0.093 0.954
Tongue (normal/abnormal) 2月27日 5月24日 1.462 0.423
Pulse condition (normal/abnormal) 5月24日 9月20日 1.506 0.358

Table 2

Comparison of effect between two groups in phase Ⅱ [Cases (%)]"

Group n Cure Obvious effect Improvment Failur Z P
ITT 2 2 2 2 2 1 1
Trial 29 14 (48.28) 8 (27.59) 5 (17.24) 2 (6.70)
-0.54 -0.59
Control 29 16 (55.17) 7 (24.14) 5 (17.24) 1 (3.45) 1 1
PP 2 2 2 2 2 11 11
Trial 28 14 (50.00) 8 (28.57) 5 (17.86) 1 (3.57)
-0.57 0.569
Control 28 16 (57.14) 7 (25.00) 5 (17.86) 0 (0.00) 1 1

Table 3

Comparison of the baseline between two groups in phase Ⅲ (ITT)"

Items Trial Control t /χ2 P
Cases 76 227 21 21
Sex(M/F) 36/40 11月16日 3.107 0.141
Mean age (x±s, year) 35.24±15.15 39.22±17.35 1.128 0.262
Course (x±s, year) 1.22±0.45 1.07±0.27 1.628 0.107
Severity (mild/moderate/severe) 26/49/1 10/17/0 0 0.996
Body temperature (x±s, ℃) 37.81±0.88 37.86±0.42 -0.321 0.749
Tongue (normal/abnormal) 6/70 4月23日 1.088 0.297
Pulse condition (normal/abnormal) 31/45 11月16日 0 0.996

Table 4

Comparison of effect between two groups in [Cases (%)]"

Group n Cure Obvious effect Improvment Failur Z P
ITT 2 2 2 2 2 1 1
Trial 76 41 (53.95) 26 (34.21) 3 (3.95) 6 (7.89)
-1.276 0.202
Control 27 12 (44.44) 7 (25.93) 6 (22.22) 2 (7.41) 1 1
PP 2 2 2 2 2 11 11
Trial 74 41 (55.41) 26 (35.14) 3 (4.05) 4 (5.41)
-1.263 0.207
Control 26 12 (46.15) 7 (26.92) 6 (23.08) 1 (3.85) 1 1
[1] Del Mar C, Glasziou P. 上呼吸道感染的治疗[J]. 中国循证医学杂志, 2004,4(4):274-277, 284
Del Mar C, Glasziou P . Treatment of upper respiratory tract infection[J]. Zhongguo Xun Zheng Yi Xue Za Zhi, 2004,4(4):274-277, 284
[2] 钱桂生 . 急性上呼吸道感染[J]. 高校保健医学研究与实践, 2005,2(1):4-5
Qian GS . Acute upper respiratory tract infection[J]. Gao Xiao Bao Jian Yi Xue Yan Jiu Yu Shi Jian, 2005,2(1):4-5
[3] 常静, 李廷谦, 万美华 , 等. 中国4种中医药大学学报随机对照临床试验文献的质量评价[J]. 中国循证医学杂志, 2006,6(3):171-178
doi: 10.3969/j.issn.1672-2531.2006.03.004
[1] Wan-jun Guo, Yi Wang, Yu Deng, Lin-yan Cheng, Xin Liu, Ruo-fan Xi, Sheng-jie Zhu, Xin-yi Feng, Liang Hua, Kan Ze, Jian-yong Zhu, Dong-jie Guo, Fu-lun Li. Therapeutic effects of the extract of Sancao Formula, a Chinese herbal compound, on imiquimod-induced psoriasis via cysteine-rich protein 61. Journal of Integrative Medicine, 2022, 20(4): 376-384.
[2] Shang-jin Song, Xuan Liu, Qing Ji, Da-zhi Sun, Li-juan Xiu, Jing-yu Xu, Xiao-qiang Yue. Ziyin Huatan Recipe, a Chinese herbal compound, inhibits migration and invasion of gastric cancer by upregulating RUNX3 expression. Journal of Integrative Medicine, 2022, 20(4): 355-364.
[3] Marisa Casal. Improving the health and treatment success rates of in vitro fertilization patients with traditional chinese medicine: need for more robust evidence and innovative approaches. Journal of Integrative Medicine, 2022, 20(3): 187-192.
[4] Ning Guo, Fei Wu, Mei Wu, Yuan Wang, Qing Lang, Xiao Lin, Yi Feng. Progress in the design and quality control of placeboes for clinical trials of traditional Chinese medicine . Journal of Integrative Medicine, 2022, 20(3): 204-212.
[5] Yan-jun Lin, Kun-li Jiao, Bo Liu, Lu Fang, Shu Meng. Antiplatelet and myocardial protective effect of shexiang tongxin dropping pill in patients undergoing percutaneous coronary intervention: A randomized controlled trial. Journal of Integrative Medicine, 2022, 20(2): 126-134.
[6] Jia-jia Li, Qing Liang, Guang-chun Sun. Traditional Chinese medicine for prevention and treatment of hepatocellular carcinoma: A focus on epithelial-mesenchymal transition. Journal of Integrative Medicine, 2021, 19(6): 469-477.
[7] Rui-jin Qiu, Min Li, Jia-yuan Hu, Jing Chen, Hong-cai Shang. Methods for development of a core outcome set for clinical trials integrating traditional Chinese medicine and Western medicine. Journal of Integrative Medicine, 2021, 19(5): 389-394.
[8] Mao-xing Pan, Chui-yang Zheng, Yuan-jun Deng, Kai-rui Tang, Huan Nie, Ji-qian Xie, Dong-dong Liu, Gui-fang Tu, Qin-he Yang, Yu-pei Zhang. Hepatic protective effects of Shenling Baizhu powder, a herbal compound, against inflammatory damage via TLR4/NLRP3 signalling pathway in rats with nonalcoholic fatty liver disease . Journal of Integrative Medicine, 2021, 19(5): 428-438.
[9] Ning Zhang, Xiao-he Xiao. Integrative medicine in the era of cancer immunotherapy: Challenges and opportunities. Journal of Integrative Medicine, 2021, 19(4): 291-294.
[10] Thomas Efferth, An-long Xu, Roxana Damiescu, Mita Banerjee, Norbert W. Paul, David Y.W. Lee. Can eastern wisdom resolve western epidemics? Traditional chinese medicine therapies and the opioid crisis. Journal of Integrative Medicine, 2021, 19(4): 295-299.
[11] Si-qi Tang, Yun-liang Wang, Zi-ye Xie, Yang Zhang, Yi Guo, Kang-li Gao, Tang-you Mao, Chun-e Xie, Jun-xiang Li, Xiao-yan Gao. Serum metabolic profiling of traditional Chinese medicine syndromes in patients with diarrhea-predominant irritable bowel syndrome. Journal of Integrative Medicine, 2021, 19(3): 274-281.
[12] Miao-yan Shi, Shi-qi Sun, Wei Zhang, Xing Zhang, Gui-hua Xu, Xuan Chen, Zi-jian Su, Xiu-ming Song, Lu-jiong Liu, Yi-bao Zhang, Yi-le Zhang, Meng Sun, Qi Chen, Yan Xue, Hua Lü, Wei-an Yuan, Xiao-rong Chen, Yun-fei Lu. Early therapeutic interventions of traditional Chinese medicine in COVID-19 patients: a retrospective cohort study. Journal of Integrative Medicine, 2021, 19(3): 226-231.
[13] Shu-jun Wei, Qing-man He, Qing Zhang, Kang-hua Fu, Ruo-lan Li, Wei Peng, Yong-xiang Gao. Traditional Chinese medicine is a useful and promising alternative strategy for treatment of Sjogren's syndrome: A review. Journal of Integrative Medicine, 2021, 19(3): 191-202.
[14] Yi Xia, Lu-shao-bo Shi, Jing-hui Chang, Hua-zhang Miao, Dong Wang. Impact of the COVID-19 pandemic on intention to use traditional Chinese medicine: A cross-sectional study based on the theory of planned behavior. Journal of Integrative Medicine, 2021, 19(3): 219-225.
[15] Na Zhi, Qian Mo, Shuo Yang, Yuan-xing Qin, Hao Chen, Zeng-guang Wu, Cai-hong Lan, Jun Zhang, Yin-long Li. Treatment of pulmonary fibrosis in one convalescent patient with corona virus disease 2019 by oral traditional Chinese medicine decoction: A case report. Journal of Integrative Medicine, 2021, 19(2): 185-190.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] Wei-xiong Liang. Problems-solving strategies in clinical treatment guideline for traditional Chinese medicine and integrative medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 1-4
[2] Zhao-guo Li. Discussion on English translation of commonly used sentences in traditional Chinese medicine: part one. Journal of Chinese Integrative Medicine, 2008, 6(1): 107-110
[3] Jun Hu, Jian-ping Liu. Non-invasive physical treatments for chronic/recurrent headache. Journal of Chinese Integrative Medicine, 2008, 6(1): 31
[4] Xue-mei Liu, Qi-fu Huang, Yun-ling Zhang, Jin-li Lou, Hong-sheng Liu, Hong Zheng. Effects of Tribulus terrestris L. saponion on apoptosis of cortical neurons induced by hypoxia-reoxygenation in rats. Journal of Chinese Integrative Medicine, 2008, 6(1): 45-50
[5] . Uniform requirements for manuscripts submitted to biomedical journals: Writing and editing for biomedical publication (Chinese version, part two). Journal of Chinese Integrative Medicine, 2010, 8(11): 1001-1005
[6] Daniel Weber, Janelle M Wheat, Geoffrey M Currie. Inflammation and cancer: Tumor initiation, progression and metastasis,and Chinese botanical medicines. Journal of Chinese Integrative Medicine, 2010, 8(11): 1006-1013
[7] Hong Liu , Guo-liang Zhang, Li Shen , Zhen Zeng, Bao-luo Zhou, Cheng-hai Liu, Guang Nie . Application and evaluation of a pseudotyped virus assay for screening herbs for anti-H5Nl avian influenza virus. Journal of Chinese Integrative Medicine, 2010, 8(11): 1036-1040
[8] Zhao-guo Li . A discussion of English translation of 1995 and 1997 Chinese National Standards of Traditional Chinese Medical Terminologies for Clinical Diagnosis and Treatment. Journal of Chinese Integrative Medicine, 2010, 8(11): 1090-1096
[9] Rui Jin, Bing Zhang. A complexity analysis of Chinese herbal property theory: the multiple formations of herbal property (Part 1). Journal of Chinese Integrative Medicine, 2012, 10(11): 1198-1205
[10] Hui-min Liu, Xian-bo Wang, Yu-juan Chang, Li-li Gu. Systematic review and meta-analysis of randomized controlled trials of integrative medicine therapy for treatment of chronic severe hepatitis. Journal of Chinese Integrative Medicine, 2012, 10(11): 1211-1228